Skip to main content

Swiss Cannabis Start-Up Raises 700K USD To Speed Up Patients Access to Medical Cannabis

Cannabissurordonnance.ch (cannabis by prescription) has developed an algorithm that helps prospective medical cannabis users to know whether they’d be eligible for treatment.

Switzerland - January 16, 2022

“Switzerland has allowed medical cannabis treatment for years, but the system makes it difficult for prospective patients to access the medication they need. We have compiled thousands of medical cannabis users' health profiles to create an algorithm that instantly tells patients whether they could benefit from a medical cannabis treatment, said Gilles Saraillon, the founder of Cannabissurordonnance.ch.

For patients, the platform has the following benefits:

- Instant Eligibility Score
- Printable Medical Cannabis Application
- Access to a wide range of medications, such as Sativex®, Epidyolex®, Dronabinol and magisterial preparations.

The platform also addresses doctors’ needs:

- Medical Cannabis Patient File Management
- Education and best practices from Medical Cannabis experts
- Scientific Board to guide them during treatment follow-up

Cannabis has a lot of possible medical applications, yet lacks thorough research

“Despite plenty of evidence regarding the efficacy, safety and lack of addiction potential, doctors are still reluctant to openly talk about cannabis treatment with their patients and still resort to classic medications such as opioids to manage pain”, says Gilles Saraillon, the founder of cannabissurordonnance.ch. “The goal is to aggregate as much relevant data as possible, so hard facts can be shown to the medical community and hopefully the cautious stance on medical cannabis will gradually shift.”

Conclusion

Cannabissurordonnance.ch accelerates the patient’s journey to medical cannabis and provides the data doctors need to make informed decisions about prescribing and managing medical cannabis patients suffering from chronic pain, anxiety, fybromyalgia, or sclerosis.

Contact Info:
Name: Gilles Saraillon
Email: Send Email
Organization: Cannabis sur Ordonnance
Address: Route de la Corniche 5, Biopôle, 1066 Epalinges, Switzerland
Website: https://www.cannabissurordonnance.ch

Release ID: 89060171

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.